People

Chuck Cleland
Charles M. Cleland, PhD
CDUHR - Co-Director, Transdisciplinary Research Methods Core
NYU Langone Health - Associate Professor, Department of Population Health
Education
PhD, Psychology, New School for Social Research
MA, Psychology, New School for Social Research
BA, Psychology, Hampden-Sydney College

Research Interests
HIV prevention, Health disparities, Substance use, Sexual health, Longitudinal data analysis
BIO
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta­-analysis, respondent­ driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.
Publications

Recent

Walker JG, Akiyama MJ, Artenie A, Cleland CM, Lizcano JA, Musyoki H, Nyakowa M, Cherutich P, Kurth AE, Vickerman P (2025).
Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya
International Journal of Drug Policy, 140, 104824. doi: 10.1016/j.drugpo.2025.104824.

Brooks MA, Rodwin AH, Gwadz M, Wilton L, Serrano S, Sherpa D, Cleland CM, Munson MR (2025).
Black and Latinx foreign- and US-born young and emerging adults living with HIV: Examining social ecological risk factors and their association with depression, post-traumatic stress Disorder (PTSD), and comorbid depression/PTSD
Journal of Racial and Ethnic Health Disparities [Epub 2025 May 7]. doi: 10.1007/s40615-025-02458-x.

Wilton L, Gwadz M, Cleland CM, Campos S, Munson MR, Dorsen C, Serrano S, Sherpa D, Saba SK, Rosmarin-DeStefano C, Filippone P (2025).
Understanding African American/Black and Latine young and emerging adults living with HIV: A sequential explanatory mixed methods study focused on self-regulatory resources
International Journal for Equity in Health, 24 (1), 120. doi: 10.1186/s12939-025-02492-5. PMCID: PMC12051309.

Cluesman SR, Gwadz M, Cleland CM (2025).
Intentions to use PrEP among a national sample of transgender and gender-expansive youth and emerging adults: Examining gender minority stress, substance use, and gender affirmation
AIDS and Behavior, 29 (5), 1428-1448. doi: 10.1007/s10461-025-04613-1.

Palamar JJ, Abukahok N, Acosta P, Krotulski AJ, Walton SE, Stang B, Cleland CM (2025).
Tusi use among the New York City nightclub-attending population
Addiction [Epub 2025 Apr 20]. doi: 10.1111/add.70069.


Notable

Kurth AE, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, Severynen AO, Clausen M, Norman RG, Lockhart D, Simoni JM, Holmes KK (2014).
Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial
Journal of Acquired Immune Deficiency Syndromes, 65 (5), 611-620. doi: 10.1097/QAI.0000000000000100. PMCID: PMC3999203.

Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, Edwards J (2014).
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
Journal of Substance Abuse Treatment, 46 (1), 43-51. doi: 10.1016/j.jsat.2013.08.012. PMCID: PMC3839618 .

Rosenblum A, Joseph H, Fong, C, Kipnis S, Cleland CM, Portenoy RK (2003).
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
Journal of the American Medical Association, 289 (18), 2370-2378. doi: 10.1001/jama.289.18.2370.

Dr. Cleland's Research Gate Profile
Selected Press